Skip to content

The Follow up of Chinese Young Children With Melamine-Related-Calculus

Part 1 The Outcome of Children With Melamine-Related-Calculus

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00895765
Enrollment
250
Registered
2009-05-08
Start date
2008-09-30
Completion date
2009-10-31
Last updated
2009-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus

Keywords

Melamine, Calculus, Kidney, Child

Brief summary

The purpose of this study is to investigate the lesions, clinical features and outcome in young children with melamine-related-calculus.

Detailed description

1. To investigate the outcome of melamine-related-calculus. * The change of calculus. * The change of obstruction features,including hydronephrosis and ureterectasia. * The change of the urinalysis. 2. To investigate the change of renal function in children with melamine-related-calculus during the follow up. * Creatinine, urea and uric acid. * α and β2 microglobulin. 3. To analysis the factors might be associated with the outcome. * The characteristics of patients: age, gender, and so on. * The characteristics of calculus: location, size, and so on.

Interventions

None listed

Sponsors

Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* children with melamine-related-calculus: with a history of melamine contaminated products * the parents leave the detailed information for contact and willing to be recalled

Exclusion criteria

* children with other congenital renal abnormality * children with hypercalciuria * children have abnormality of parathyroid gland

Design outcomes

Primary

MeasureTime frame
The calculus measured by sonographyat 1, 3, 6 and 12 months

Secondary

MeasureTime frame
Renal function (e.g., creatinine, microglobulin)at 1, 3, 6 and 12 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026